These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12444919)

  • 1. The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.
    Fox EJ; Wright SC
    Biochem J; 2003 Feb; 370(Pt 1):307-13. PubMed ID: 12444919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct repression of the Mcl-1 promoter by E2F1.
    Croxton R; Ma Y; Song L; Haura EB; Cress WD
    Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.
    Croxton R; Ma Y; Cress WD
    Oncogene; 2002 Feb; 21(10):1563-70. PubMed ID: 11896585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
    Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
    Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.
    Di Stefano L; Jensen MR; Helin K
    EMBO J; 2003 Dec; 22(23):6289-98. PubMed ID: 14633988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
    Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q; Li J; Cenkci B; Kretzner L
    Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
    Kime L; Wright SC
    Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of human fibroblast growth factor receptor 1 by E2F-1.
    Kanai M; Tashiro E; Maruki H; Minato Y; Imoto M
    Gene; 2009 Jun; 438(1-2):49-56. PubMed ID: 19303924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.
    Imaki H; Nakayama K; Delehouzee S; Handa H; Kitagawa M; Kamura T; Nakayama KI
    Cancer Res; 2003 Aug; 63(15):4607-13. PubMed ID: 12907639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
    Kwon JA; Rho HM
    Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel E2F1-regulated genes by microarray.
    Ma Y; Croxton R; Moorer RL; Cress WD
    Arch Biochem Biophys; 2002 Mar; 399(2):212-24. PubMed ID: 11888208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.